Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β
- 11 January 2002
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 290 (1), 91-96
- https://doi.org/10.1006/bbrc.2001.6179
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Tumor-Induced Immunosuppression: A Barrier to Immunotherapy of Large Tumors by Cytokine-Secreting Tumor VaccineHuman Gene Therapy, 2000
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cellsGene Therapy, 1997
- Cannabinoid Receptors CB1 and CB2: A Characterization of Expression and Adenylate Cyclase Modulation within the Immune SystemToxicology and Applied Pharmacology, 1997
- Molecular Aspects of Cannabinoid ReceptorsCritical Reviews™ in Neurobiology, 1997
- Delta-9-tetrahydrocannabinol suppresses tumor necrosis factor α maturation and secretion but not its transcription in mouse macrophagesInternational Journal of Immunopharmacology, 1996
- Effect of the Psychoactive Metabolite of Marijuana, Δ9-Tetrahydrocannabinol (THC), on the Synthesis of Tumor Necrosis Factor by Human Large Granular LymphocytesCellular Immunology, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Differential effect of transforming growth factor β on the synthesis of Th1‐ and Th2‐like lymphokines by human T lymphocytesEuropean Journal of Immunology, 1992
- The glioblastoma‐derived t cell suppressor factor/ transforming growth factor‐β2 inhibits t cell growth without affecting the interaction of interleukin 2 with its receptorEuropean Journal of Immunology, 1988